2011-12
2014-12
2014-12
400
NCT01698190
Stony Brook University
Stony Brook University
INTERVENTIONAL
Comparing the Efficacy of Endoscopic FNA vs FNB in Diagnosing Solid Gastrointestinal Lesions
The purpose of this study is to determine if fine needle aspiration or fine needle biopsy is more efficacious and cost-effective than the other while maintaining diagnostic accuracy in the setting of solid gastrointestinal lesions.
When ultrasound is used during endoscopy, we are able to visualize the structures adjacent to the gastrointestinal tract in close detail. Once the mass is visualized, we use endoscopic ultrasound to obtain a tissue sample, which the pathologist can examine in order to provide a diagnosis. The conventional method for obtaining a sample of tissue with endoscopic ultrasound is called fine needle aspiration (FNA). This involves the insertion of a thin needle into the mass and obtaining a small sample of tissue which the pathologist can examine. An alternative technique is called fine needle biopsy (FNB), and involves the insertion of a thin double-edged needle into the mass. This double-edged needle may potentially provide a larger sample of tissue to examine. Both of these techniques are commonly used, and both methods are equally safe. However, it is not known if one of these techniques is more effective at obtaining a sample of tissue or if one of these techniques is more cost-effective than the other. The purpose of this study is to determine if one method is more efficacious and cost-effective than the other while maintaining diagnostic accuracy. The results of this study may alter the way gastroenterologists obtain tissue samples during endoscopic ultrasound, improving the utility of the exam and reducing unnecessary healthcare costs.
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates | Results Reporting Dates | Study Record Updates |
---|---|---|
2012-05-25 | N/A | 2014-11-18 |
2012-09-28 | N/A | 2014-11-19 |
2012-10-02 | N/A | 2014-11 |
This section provides details of the study plan, including how the study is designed and what the study is measuring.
Primary Purpose:
Diagnostic
Allocation:
Randomized
Interventional Model:
Crossover
Masking:
Single
Arms and Interventions
Participant Group/Arm | Intervention/Treatment |
---|---|
ACTIVE_COMPARATOR: Fine needle aspiration (FNA) Endoscopic ultrasound guided needle tissue acquisition: Tissue acquisition using a standard FNA needle | PROCEDURE: Endoscopic ultrasound guided needle tissue acquisition.
|
ACTIVE_COMPARATOR: Fine needle biopsy (FNB) Endoscopic ultrasound guided needle tissue acquisition: Tissue acquisition using a new Core needle (Procore; Fine Needle Biopsy). | PROCEDURE: Endoscopic ultrasound guided needle tissue acquisition.
|
Primary Outcome Measures | Measure Description | Time Frame |
---|---|---|
Number of needle passes needed to obtain a pathologic diagnosis. | Within 1 week of study enrollment |
Secondary Outcome Measures | Measure Description | Time Frame |
---|---|---|
Diagnostic yield, defined as percentage of cases with a diagnostic biopsy sample, between FNA and FNB. | By three months post-op in the pathology report | |
Visible core specimens obtained and its correlation to obtaining a diagnostic sample. | During the intervention itself | |
Frequency of adverse side effects. | Three months post-op |
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact Name: Satish Nagula, M.D. Phone Number: 631-444-2119 Email: satish.nagula@stonybrookmedicine.edu |
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.
Ages Eligible for Study:
ALL
Sexes Eligible for Study:
18 Years
Accepts Healthy Volunteers:
This is where you will find people and organizations involved with this study.
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
NPCF was founded on May 29, 2009 and is a 501(c)(3) organization. All donations are tax deductible.
The information and services provided by the National Pancreatic Cancer Foundation are for informational purposes only. The information and services are not intended to be substitutes for professional medical advice, diagnosis or treatment. The National Pancreatic Cancer Foundation does not recommend nor endorse any specific physicians, products or treatments even though they may be mentioned on this site.